Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

MuLV packaging systems as models for estimating/measuring retrovirus recombination frequency.

C Patience1, Y Takeuch, F L Cosset

  • 1Chester Beatty Laboratories, Institute of Cancer Research, London, UK.

Developments in Biologicals
|January 5, 2002
PubMed
Summary

Gene therapy retrovirus vectors show lower contamination with endogenous viral sequences in human packaging cells compared to murine ones. This finding is crucial for improving the safety of gene therapy development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tough Stretchable Physically-Cross-linked Electrospun Hydrogel Fiber Mats.

ACS applied materials & interfaces·2016
Same author

Supramolecular Hydrophobic Aggregates in Hydrogels Partially Inhibit Ice Formation.

The journal of physical chemistry. B·2016
Same author

Tailor-Made Fluorinated Copolymer/Clay Nanocomposite by Cationic RAFT Assisted Pickering Miniemulsion Polymerization.

Langmuir : the ACS journal of surfaces and colloids·2015
Same author

Hybridomas produce viruses as well as antibodies.

Immunology today·2014
Same author

Overcoming confinement limited swelling in hydrogel thin films using supramolecular interactions.

Soft matter·2014
Same author

Lithium-end-capped polylactide thin films influence osteoblast progenitor cell differentiation and mineralization.

Journal of biomedical materials research. Part A·2014

Area of Science:

  • Retroviral research
  • Gene therapy vectorology
  • Molecular virology

Background:

  • Retrovirus vectors can interact with endogenous retroviruses in packaging and target cells, potentially forming recombinant viruses.
  • Assessing contamination of retroviral vectors with endogenous viral sequences is critical for gene therapy safety.

Purpose of the Study:

  • To investigate the incorporation of endogenous retrovirus transcripts into murine leukemia virus (MLV) vector particles from human and murine packaging cell lines.
  • To determine if vector genomes are packaged into human endogenous retrovirus (HERV) particles.

Main Methods:

  • Sensitive reverse transcription-polymerase chain reaction (RT-PCR) assays were employed.
  • Analysis of retroviral particles produced by murine AM12 and human FLY packaging cell lines.

Related Experiment Videos

  • Quantification of endogenous retrovirus sequences and vector genomes within packaged particles.

    • Main Results:

    • Murine packaging cells (AM12) packaged VL30 endogenous retrovirus sequences into MLV vector particles.
    • Human packaging cells (FLY) showed minimal to no detectable HERV transcripts in MLV vector particles.
    • MLV vector transcripts were detected at a very low level in human FLY virions, and HERV-K particles did not package MLV-based vectors.

    Conclusions:

    • Human packaging cell lines produce retrovirus particles with significantly less contamination from endogenous viral sequences compared to murine packaging cells.
    • This suggests human packaging cells offer a safer platform for retroviral vector production in gene therapy.
    • Findings highlight the importance of cell line choice in minimizing risks associated with retroviral vector contamination.